RCAN1-mediated calcineurin inhibition as a target for cancer therapy.

Lao, Mengyi; Zhang, Xiaozhen; Yang, Hanshen; Bai, Xueli; Liang, Tingbo

Lao, Mengyi; Zhang, Xiaozhen; Yang, Hanshen; Bai, Xueli; Liang, Tingbo.

Afiliação

Lao M; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310009, Zhejiang, China.
Zhang X; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, Zhejiang, China.
Yang H; Zhejiang Provincial Innovation Center for the Study of Pancreatic Diseases, Hangzhou, 310009, Zhejiang, China.
Bai X; Zhejiang Provincial Clinical Research Center for the Study of Hepatobiliary and Pancreatic Diseases, Hangzhou, 310009, Zhejiang, China.
Liang T; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310009, Zhejiang, China.

Mol Med ; 28(1): 69, 2022 06 18.

Article em En | MEDLINE | ID: mdl-35717152

Assuntos

Calcineurina; Neoplasias; Calcineurina/metabolismo; Proteínas de Ligação a DNA; Humanos; Peptídeos e Proteínas de Sinalização Intracelular; Proteínas Musculares/metabolismo; Fatores de Transcrição NFATC/metabolismo; Neoplasias/tratamento farmacológico

Palavras-chave

Calcineurin; Cancer therapy; RCAN1

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Calcineurina / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Calcineurina / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article